GENEVA, LAUSANNE, 31 March 2021: Cocaine is a highly addictive substance that, in the long term, can have adverse effects on health and wellbeing. There are around 18 million cocaine users globally, according to a UN report. Understanding how cocaine modifies brain networks could reveal potential targets for therapies to treat addiction and other neuropsychological disorders.
A new study published today in the journal
Frontiers in Synaptic Neuroscience
by a team of researchers from the University of Lausanne and the Wyss Center for Bio and Neuroengineering reveals that during cocaine withdrawal, neurons in a brain area associated with depression connect to neurons embedded in an anti-reward system.
When we receive a reward, neurons fire in the brain’s ventral tegmental area (VTA) – a region of the brain that produces dopamine. Dopamine is a chemical messenger that creates feelings of joy or pleasure. It spreads throughout the brain, motivating us to repeat our actions and achieve the feeling of pleasure again, a central facet of addictive behavior.
When we miss out on a reward, or stop taking an addictive drug, the lateral habenula – a brain area linked to depression – becomes hyperactive and sends signals to the VTA that results in depressive symptoms.
What researchers did not know, until now, is exactly where the neurons from the lateral habenula extend into the VTA and what they connect to during withdrawal from cocaine. Through a series of experiments, the team discovered that, in mice, the neurons from the lateral habenula synapse mostly to neurons in the VTA that do not produce dopamine, creating a connection to an anti-reward system that may be key in driving adverse behavior.
Manuel Mameli, PhD, Associate Professor in the Department of Fundamental Neuroscience, University of Lausanne said: “We wanted to understand why individuals experience depression when they stop taking a substance like cocaine. We knew that cocaine withdrawal induces changes to brain circuits linked to depression and reward, but our results have now taken us a step further and show that there is a reorganization of brain circuits that drive negative behavior.”
The team combined their expertise in sample preparation and advanced microscopy to capture 3D images of entire intact mouse brains. They used viral ‘tags’ to make the neurons fluoresce, then created completely transparent samples by removing lipids, before imaging with the Wyss Center’s custom-built lightsheet microscope. With data analytics and visualization tools, they identified the 3D morphology of specific neurons to understand their anatomical distribution inside the brain.
Stephane Pages, PhD, Scientific Coordinator at the Wyss Center and Senior Research Associate at the University of Geneva said: “The beauty of lightsheet imaging is being able to see which neurons connect to each other in the brain. Our microscope and data analytics capabilities pinpointed the specific neuronal connections between the two major brain areas implicated in drug withdrawal.”
The results of the study also show that neurons in the anti-reward circuits not only project to the VTA but also from there into other parts of the brain resulting in a cascade of ‘anti-reward’ information into areas responsible for decision making and motivation, amongst others. The next step is to dissect the functionality of these non-dopamine, anti-reward, circuits to better understand how they influence behavior.
The paper: Output-specific adaptation of habenula-midbrain excitatory synapses during cocaine withdrawal by Joseph Clerke, Patricia Preston-Ferrer, Ioannis S. Zouridis, Audrey Tissot, Laura Batti,
Fabian F. Voigt, Stéphane Pagès, Andrea Burgalossi and Manuel Mameli is published in
Frontiers in Synaptic Neuroscience
, doi 10.3389/fnsyn.2021.643138.
Image caption: Neurons from the lateral habenula (green) mostly connect to an anti-reward network of non-dopamine neurons in the VTA. Dopamine neurons are shown in purple. Although there are some connections between the green neurons from the lateral habenula and purple dopamine neurons, these are not the majority.
Image credit: Mameli Lab, University of Lausanne
About the Wyss Center for Bio and Neuroengineering, Geneva, Switzerland
The Wyss Center is an independent, non-profit research and development organization that advances our understanding of the brain to realize therapies and improve lives.
The Wyss Center staff, together with the Center’s academic, clinical and industrial collaborators, pursue innovations and new approaches in neurobiology, neuroimaging and neurotechnology.
Wyss Center advances reveal unique insights into the mechanisms underlying the dynamics of the brain and the treatment of disease to accelerate the development of devices and therapies for unmet medical needs.
The Wyss Center was established by a generous donation from the Swiss entrepreneur and philanthropist Hansjörg Wyss in 2014. Additional resources from funding agencies and other sources help the Wyss Center accelerate its mission.
Jo Bowler, Communications Manager
+41 (0) 58 201 03 09
This part of information is sourced from https://www.eurekalert.org/pub_releases/2021-03/wcfb-sct033021.php